144 related articles for article (PubMed ID: 21689771)
1. Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ 1-42 oligomer injection.
Choi JG; Moon M; Kim HG; Mook-Jung I; Chung SY; Kang TH; Kim SY; Lee EH; Oh MS
Neurobiol Learn Mem; 2011 Sep; 96(2):306-14. PubMed ID: 21689771
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice.
Moon M; Choi JG; Nam DW; Hong HS; Choi YJ; Oh MS; Mook-Jung I
J Alzheimers Dis; 2011; 23(1):147-59. PubMed ID: 20930280
[TBL] [Abstract][Full Text] [Related]
3. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD.
Tohda C; Nakada R; Urano T; Okonogi A; Kuboyama T
Int J Neurosci; 2011 Dec; 121(12):641-8. PubMed ID: 21770858
[TBL] [Abstract][Full Text] [Related]
4. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
5. Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo.
Kim HG; Moon M; Choi JG; Park G; Kim AJ; Hur J; Lee KT; Oh MS
Neurotoxicology; 2014 Jan; 40():23-32. PubMed ID: 24189446
[TBL] [Abstract][Full Text] [Related]
6. 4-O-methylhonokiol attenuated β-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase.
Lee YK; Choi IS; Ban JO; Lee HJ; Lee US; Han SB; Jung JK; Kim YH; Kim KH; Oh KW; Hong JT
J Nutr Biochem; 2011 May; 22(5):476-86. PubMed ID: 20688501
[TBL] [Abstract][Full Text] [Related]
7. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
8. Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer's disease.
Iwasaki Y; Negishi T; Inoue M; Tashiro T; Tabira T; Kimura N
J Neurosci Res; 2012 May; 90(5):981-9. PubMed ID: 22252710
[TBL] [Abstract][Full Text] [Related]
9. The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model.
Figueiró M; Ilha J; Linck VM; Herrmann AP; Nardin P; Menezes CB; Achaval M; Gonçalves CA; Porciúncula LO; Nunes DS; Elisabetsky E
Phytomedicine; 2011 Feb; 18(4):327-33. PubMed ID: 20739160
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
11. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo.
Li J; Wang G; Liu J; Zhou L; Dong M; Wang R; Li X; Li X; Lin C; Niu Y
Eur J Pharmacol; 2010 Dec; 649(1-3):195-201. PubMed ID: 20868658
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
Bate C; Williams A
J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo.
Kim HG; Kim JY; Whang WW; Oh MS
Can J Physiol Pharmacol; 2014 Jun; 92(6):429-37. PubMed ID: 24820962
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease.
Inestrosa NC; Carvajal FJ; Zolezzi JM; Tapia-Rojas C; Serrano F; Karmelic D; Toledo EM; Toro A; Toro J; Santos MJ
J Alzheimers Dis; 2013; 33(4):941-59. PubMed ID: 23109558
[TBL] [Abstract][Full Text] [Related]
16. Operational dissection of β-amyloid cytopathic effects on cultured neurons.
Callizot N; Combes M; Steinschneider R; Poindron P
J Neurosci Res; 2013 May; 91(5):706-16. PubMed ID: 23404368
[TBL] [Abstract][Full Text] [Related]
17. Aβ25-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats.
Diaz A; Limon D; Chávez R; Zenteno E; Guevara J
J Alzheimers Dis; 2012; 30(3):505-22. PubMed ID: 22430532
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus.
Stepanichev MY; Zdobnova IM; Zarubenko II; Moiseeva YV; Lazareva NA; Onufriev MV; Gulyaeva NV
Physiol Behav; 2004 Feb; 80(5):647-55. PubMed ID: 14984798
[TBL] [Abstract][Full Text] [Related]
19. The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice.
Kim DH; Kim S; Jeon SJ; Son KH; Lee S; Yoon BH; Cheong JH; Ko KH; Ryu JH
Neuropharmacology; 2008 Oct; 55(5):639-47. PubMed ID: 18620712
[TBL] [Abstract][Full Text] [Related]
20. Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways.
Morroni F; Sita G; Tarozzi A; Rimondini R; Hrelia P
Behav Brain Res; 2016 Nov; 314():106-15. PubMed ID: 27498145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
